International Patent Roundtable Featuring Comparative Discussion of Product-by-Process Claim Strategy in the U.S. and Japan
26 June 2017
In the case of emerging technologies such as stem cells and nanotechnology, inventions are frequently claimed in product-by-process format when the exact physical differences of the end products are not yet known. Recent Supreme Court precedent in Japan has created turmoil for patent applicants seeking to pursue product-by-process claims, though they remain a well-accepted claiming format in the U.S.
Join us for an interactive roundtable discussion of comparative claim drafting strategies for protecting these types of inventions in the U.S. and Japan, as well as opportunities for enforcing, challenging, and defending these types of claims.
People
Related Insights
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.
June 3, 2025
Health Care Law Today
Risk Bearing Entity Requirements: Massachusetts
This blog discusses the regulatory requirements that apply to risk-bearing entities in Massachusetts, including recent updates introduced by Chapter 343 of the Massachusetts Acts of 2024.
June 2, 2025
Labor & Employment Law Perspectives
Update on DHS Efforts to Terminate TPS and Parole Status for Various Immigrant Groups
The U.S. Department of Homeland Security (DHS) has been actively working to terminate Temporary Protected Status (TPS) and Parole status…